Finance

Lists
4AB:FRA
AbbVie Common Stock
221,60 €
+2,55%
(+5,50) 1D
11 სექ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4AB...
Open
218,60 €
High
221,60 €
Low
218,60 €
Mkt. cap
454,36 მლრ.
Avg. vol.
59,00
Volume
16,00
52-wk high
234,40 €
52-wk low
167,55 €
No. of employees
57 ათ.
Open
218,60 €
High
221,60 €
Low
218,60 €
Mkt. cap
454,36 მლრ.
Avg. vol.
59,00
Volume
16,00
52-wk high
234,40 €
52-wk low
167,55 €
No. of employees
57 ათ.
News stories
From web sources and news partners
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEOრობერ ეი მაიკლ
Employees57 ათ.
Founded10 აპრ. 2012
HeadquartersNorth Chicago, ილინოისი, ამერიკის შეერთებული შტატები
Sector-
Websiteabbvie.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
15,78 მლრდ.
16,62 მლრდ.
15,00 მლრდ.
16,99 მლრდ.
Cost of goods sold
4,46 მლრდ.
4,55 მლრდ.
4,22 მლრდ.
4,29 მლრდ.
Cost of revenue
4,46 მლრდ.
4,55 მლრდ.
4,22 მლრდ.
4,29 მლრდ.
Research and development expenses
2,29 მლრდ.
2,58 მლრდ.
2,47 მლრდ.
2,34 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,43 მლრდ.
3,82 მლრდ.
3,49 მლრდ.
3,55 მლრდ.
Operating expense
5,72 მლრდ.
6,40 მლრდ.
5,96 მლრდ.
5,90 მლრდ.
Total operating expenses
10,18 მლრდ.
10,95 მლრდ.
10,18 მლრდ.
10,19 მლრდ.
Operating income
5,60 მლრდ.
5,67 მლრდ.
4,82 მლრდ.
6,80 მლრდ.
Other non operating income
199,00 მლნ.
120,00 მლნ.
-3,00 მლნ.
-55,00 მლნ.
EBT including unusual items
714,00 მლნ.
2,67 მლრდ.
1,04 მლრდ.
4,28 მლრდ.
EBT excluding unusual items
5,11 მლრდ.
5,12 მლრდ.
4,19 მლრდ.
6,07 მლრდ.
Income tax expense
526,00 მლნ.
853,00 მლნ.
342,00 მლნ.
662,00 მლნ.
Effective tax rate
73,67%
31,97%
32,92%
15,47%
Other operating expenses
-
-
-
-
Net income
186,00 მლნ.
1,82 მლრდ.
695,00 მლნ.
3,61 მლრდ.
Net profit margin
1,18%
10,93%
4,63%
21,27%
Earnings per share
1,86
2,71
2,65
3,65
Interest and investment income
72,00 მლნ.
59,00 მლნ.
72,00 მლნ.
67,00 მლნ.
Interest expense
-739,00 მლნ.
-714,00 მლნ.
-717,00 მლნ.
-746,00 მლნ.
Net interest expenses
-667,00 მლნ.
-655,00 მლნ.
-645,00 მლნ.
-679,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,66 მლრდ.
7,66 მლრდ.
6,76 მლრდ.
8,68 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები